| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | $1.37B |
| R&D | $34.88M | – | – | – | – |
| SG&A | $39.33M | $42.03M | $37.46M | $33.41M | $68.05M |
| Operating Income | $65.23M | $3.97M | -$24.41M | -$380.39M | -$140.46M |
| Interest Expense | $863.00K | $2.06M | $994.00K | $894.00K | $2.63M |
| Tax Expense | $8.12M | -$7.79M | -$5.99M | -$16.21M | -$22.57M |
| Net Income | $48.09M | -$1.13M | -$22.01M | -$357.82M | -$128.13M |
| EPS (basic) | 0.3000 | -0.0100 | -0.1400 | -2.2000 | – |
| EPS (diluted) | 0.3000 | -0.0100 | -0.1400 | -2.2000 | – |
| Shares (diluted) | $162.19M | $161.62M | $162.16M | $162.82M | – |